Overview

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

Full Product Details

9783030256128

Table of Contents

Reviews

This is a well-written, comprehensive book for those who specialize in lymphomas. Tables, illustrations, and figures allow for easy referencing. ... This book is intended for lymphoma specialists and hematologists who see these rare lymphomas. ... I highly recommend this book to those who specialize in lymphomas. (Harsh Rohit Shah, Doody's Book Reviews, March 20, 2020)

Author Information

Christopher Dittus, DO, MPH Assistant Professor of Medicine Division of Hematology/Oncology, Lymphoma Program University of North Carolina, Chapel Hill

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available